Related Experiment Video
Updated: Feb 20, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Multidrug Resistant Pseudomonas aeruginosa Causing Prosthetic Valve Endocarditis: A Genetic-Based Chronicle of
T Nicholas Domitrovic1,2, Andrea M Hujer1,2, Federico Perez1,2
1Louis Stokes Cleveland Department of Veterans Affairs Medical Center.
Abstract:
Successful treatment of infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa is thwarted by the emergence of antibiotic resistance and biofilm formation on prosthetic devices. Our aims were to decipher the molecular basis of resistance in a unique case of prosthetic valve endocarditis (PVE) caused by MDR P. aeruginosa. Five sequential MDR P. aeruginosa blood isolates collected during a 7-month period were recovered from a patient suffering from PVE previously exposed to β-lactam antibiotics. Minimum inhibitory concentrations (MICs) of several classes of antibiotics were used to indicate clinical resistance characteristics; relatedness of the isolates was determined using multilocus sequence typing and repetitive sequence-based polymerase chain reaction. Amplification and sequencing of regulatory and resistance genes was performed. All isolates belonged to ST 298, possessed blaPDC-16, and were resistant to fluoroquinolones and carbapenems. In the course of therapy, we observed a >2-fold increase in cephalosporin resistance (4 µg/mL to >16 µg/mL). Sequencing of the AmpC regulator, ampR, revealed a D135N point mutation in cephalosporin-resistant isolates. Common carbapenemase genes were not identified. All isolates demonstrated a premature stop codon at amino acid 79 of the outer membrane protein OprD and mutations in the quinolone resistance-determining regions of gyrA and parC. Point mutations in nalC, an efflux pump regulator, were also observed. In this analysis, we chart the molecular evolution of β-lactam resistance in a case of PVE. We show that mutations in regulatory genes controlling efflux and cephalosporinase production contributed to the MDR phenotype.
Insights
This study tracked multidrug-resistant Pseudomonas aeruginosa in a prosthetic valve endocarditis patient, revealing how mutations in regulatory genes drive antibiotic resistance and treatment failure.
Area of Science:
- Medical Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Multidrug-resistant (MDR) *Pseudomonas aeruginosa* poses a significant challenge in treating infections, particularly those involving prosthetic devices like prosthetic valve endocarditis (PVE).
- Antibiotic resistance and biofilm formation are key factors complicating treatment outcomes.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the emergence of antibiotic resistance in MDR *P. aeruginosa* during treatment for PVE.
- To identify specific genetic mutations contributing to the observed resistance patterns.
Main Methods:
- Analysis of five sequential MDR *P. aeruginosa* blood isolates from a PVE patient over seven months.
- Determination of antibiotic resistance profiles using Minimum Inhibitory Concentrations (MICs).
- Molecular characterization including multilocus sequence typing (MLST), repetitive sequence-based PCR, and gene sequencing (regulatory and resistance genes).
Main Results:
- All isolates belonged to Sequence Type 298 (ST 298) and exhibited resistance to fluoroquinolones and carbapenems, possessing the *bla*PDC-16 gene.
- A significant increase in cephalosporin resistance was observed during therapy, correlated with a D135N mutation in the *amp*R regulator.
- Mutations were identified in the outer membrane protein OprD, quinolone resistance-determining regions of *gyr*A and *par*C, and the efflux pump regulator *nal*C.
Conclusions:
- The study elucidates the molecular evolution of β-lactam resistance in *P. aeruginosa* within a PVE context.
- Mutations in regulatory genes governing efflux pumps and cephalosporinase production are critical contributors to the MDR phenotype, impacting treatment efficacy.
Related Concept Videos
Development of Antibiotic Resistance
Endocarditis I: Introduction
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection
Endocarditis III: Medical Management
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

